Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Jotaro

Jotaro Akiyama, Tsukaba Ibaraki JP

Patent application numberDescriptionPublished
20090243100Methods to Form a Three-Dimensionally Curved Pad in a Substrate and Integrated Circuits Incorporating such a Substrate - Methods to form a three-dimensionally curved pad in a substrate and integrated circuits incorporating such a substrate are disclosed. An example method to form a three-dimensionally curved pad comprises isotropically etching a portion of a surface of a substrate to form a recess having a radial shape, forming a conductive layer in the recess to form the bonding pad, and placing a conductive element in the pad.10-01-2009

Jotaro Miyata, Komaki-City JP

Patent application numberDescriptionPublished
20080272111SUPPORT STRUCTURE OF HEATER - There is provided an electric heater support plate which is not likely to be softened or deformed during firing at a high temperature, even if a material to be fired contains an alkaline component or an Si component as a volatile component. A passage 11-06-2008
20080280244METHOD OF DISCHARGING GAS FROM CONTINUOUS OVEN AND GAS DISCHARGE STRUCTURE - A to-be-burned object including a metal Si component or SiC or Si11-13-2008

Jotaro Nagao, Yokohama-Shi JP

Patent application numberDescriptionPublished
20100233398CUP-TYPE POLYPROPYLENE CONTAINER AND METHOD OF MOLDING THE SAME - A cup-type polypropylene container obtained by compression-molding a polypropylene and having at least a body portion and a bottom portion, wherein the body portion has a thickness of not larger than 1.0 mm and a value K09-16-2010

Jotaro Nakanishi, Yokohama-Shi JP

Patent application numberDescriptionPublished
20090123572Method and Pharmaceutical Composition for Treating Psoriasis, Squamous Cell Carcinoma and/or Parakeratosis by Inhibiting Expression of Squamous Cell Carcinoma-Related Antigen - In a first aspect thereof, the present invention provides a method for treatment and/or prevention of a disease selected from the group consisting of psoriasis and squamous cell carcinoma by inhibiting the expression of squamous cell carcinoma antigen (SCCA) by cells. In another aspect thereof, the present invention provides a method for screening for substances that inhibit epidermal parakeratosis, wherein the activity of a candidate substance that inhibits cysteine protease inhibitory activity possessed by squamous cell carcinoma antigen 1 (SCCA-1) is used as an indicator.05-14-2009
20110091387METHODS AND COMPOSITIONS FOR REDUCING SKIN DAMAGE - The RhoE GTPase pathway has been identified as a target for screening and treatment methods for the prevention and/or reduction of short- and long-term UVB-induced skin damage, e.g., the prevention and/or reduction of UVB-induced wrinkles. The invention thus features screening and treatment methods for prevention or reduction of UVB-induced sin damage, and related compositions, e.g., cosmetic compositions.04-21-2011

Patent applications by Jotaro Nakanishi, Yokohama-Shi JP

Jotaro Suzuki, Tokyo JP

Patent application numberDescriptionPublished
20080306046Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Derivative - [Problem] To provide a compound usable for treatment of diseases associated with fatty acid amide hydrolase (FAAH), especially for treatment of urinary frequency and urinary incontinence, overactive bladder and/or pain.12-11-2008
20100009971Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound - A novel pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound or its pharmaceutically acceptable salt has a potent FAAH-inhibitory activity. Further, the pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound of the present disclosure is also useful in the treatment of urinary frequency and urinary incontinence, overactive bladder and/or pain.01-14-2010
20100009972Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound - A novel pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound and its pharmaceutically acceptable salt has a potent FAAH-inhibitory activity. Further, the pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound of the present disclosure is also useful in the treatment of urinary frequency and urinary incontinence, overactive bladder and/or pain.01-14-2010